Hearts and Minds Investments Ltd ( (AU:HM1) ) has provided an announcement.
Hearts and Minds Investments Limited announced a significant write-down of its holding in Opthea Limited, a biopharmaceutical company specializing in eye disease treatments. The decision to reduce the value of Opthea shares to zero follows the failure of a second phase three trial for a treatment, impacting HM1’s net asset value by approximately 0.8%.
More about Hearts and Minds Investments Ltd
Hearts and Minds Investments Limited operates in the investment industry, focusing on managing a diverse portfolio of assets. The company aims to deliver superior investment returns by leveraging insights from leading fund managers and industry experts.
YTD Price Performance: -3.64%
Average Trading Volume: 217,157
Technical Sentiment Signal: Sell
See more data about HM1 stock on TipRanks’ Stock Analysis page.